Multicenter, Open-Label, Trial of Sarizotan in Parkinson Disease Patients With Levodopa-Induced Dyskinesias (the SPLENDID Study)
Authors:
- Philippe DamierPDPhilippe Damier
- Christopher G. GoetzCGChristopher G. Goetz
- Thomas MuellerTMThomas Mueller
- John NuttJNJohn Nutt
- Olivier RascolOROlivier Rascol
- Alexandru SerbanescuASAlexandru Serbanescu
- Frieda DeckersFDFrieda Deckers
- Hermann RussHRHermann Russ
- 1 January 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 27 (2) , 58-62
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian modelsNeurology, 2001
- An algorithm (decision tree) for the management of Parkinson’s disease (2001):Neurology, 2001
- Dyskinesias and motor fluctuations in Parkinson's diseaseBrain, 2000
- A Home Diary to Assess Functional Status in Patients with Parkinson's Disease with Motor Fluctuations and DyskinesiaClinical Neuropharmacology, 2000
- Advantages of a modified scoring method for the rush video-based tic rating scaleMovement Disorders, 1999
- Core assessment program for intracerebral transplantations (CAPIT)Movement Disorders, 1992
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- A RAPID TEST OF ADRENOCORTICAL FUNCTIONThe Lancet, 1965